Preliminary analysis of Plasmodium vivax genotypes isolated in southeastern Turkey
Plasmodium vivax is the most common cause of malaria worldwide as well as southeastern Turkey. After the implementation of a successful national elimination program that the local malaria cases were not reported in 2011, malaria returned to county of Savur located in southeastern Turkey in summer of 2012. The present study aimed to determine the prevalent P. vivax genotypes isolated from southeastern Turkey. Genetic polymorphism in P. vivax CSP gene was analyzed by PCR-RFLP to assess the ratio of VK210 and VK247 types. Blood samples were obtained from 15 patients who lived in southeastern between 2005–2006. According to the results, VK210 type was detected in 10 samples (66.6%), VK247 type was observed in three samples (20%). Remaining two samples showed mixed infection (13.3%). The results of the present study first time showed the ratio of P. vivax genotypes in southeastern Turkey before the elimination in 2011. The results of the present study will be enable researchers to compare the new isolates with the previously detected ones and design new treatment and/elimination strategies.
KeywordsMalaria Plasmodium vivax VK210 VK247 Turkey
Unable to display preview. Download preview PDF.
- Inspection and evaluation report of malaria outbreak occurred in Savur, Mardin, 2012. Turkish Medical Association publications.Google Scholar
- Machado R.L., Póvoa M.M. 2000. Distribution of Plasmodium vivax variants (VK210, VK247 and P. vivax-like) in three endemic areas of the Amazon region of Brazil and their correlation with chloroquine treatment. Transactions of the Royal Society of Tropical Medicine and Hygiene, 94, 377–381CrossRefGoogle Scholar
- Malaria Surveillance Directorate statistics about Malaria, Ministry of Health, Republic of Turkey, 2014. http://www.saglik.gov.tr/TR/belge/1-3416/sitma-savas-daire-baskanliginin-sitma-ileilgili-istati-.html. Accessed November 18, 2014
- World Health Organization, 2012. Plasmodium vivax Control & Elimination: Development of Global Strategy and Investment Case, Malaria Policy Advisory Committee Meeting, http://www.who.int/malaria/mpac/sep2012/pvivax_development_global_strategy_and_investment_sep2012.pdf. Accessed November 18, 2014Google Scholar
- Zakeri S., Raeisi A., Afsharpad M., Kakar Q., Ghasemi F., Atta H., Zamani G., Memon M.S., Salehi M., Djadid N.D. 2010b. Molecular characterization of Plasmodium vivax clinical isolates in Pakistan and Iran using pvmsp-1, pvmsp-3alpha and pvcsp genes as molecular markers. Parasitology International, 59, 15–21CrossRefGoogle Scholar